Royal Bank of Canada Issues Pessimistic Forecast for Addus HomeCare (NASDAQ:ADUS) Stock Price

Addus HomeCare (NASDAQ:ADUS) had its price target reduced by Royal Bank of Canada from $141.00 to $136.00 in a report published on Wednesday,Benzinga reports. They currently have an outperform rating on the stock.

Other analysts have also recently issued reports about the company. Macquarie reaffirmed an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. TD Cowen increased their price target on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Stephens reissued an “overweight” rating and issued a $138.00 price objective on shares of Addus HomeCare in a research note on Tuesday, August 6th. KeyCorp began coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective for the company. Finally, Oppenheimer lifted their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. One research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $131.63.

Addus HomeCare Trading Down 1.2 %

Shares of ADUS opened at $127.58 on Wednesday. The company’s 50 day simple moving average is $129.60 and its 200-day simple moving average is $121.40. The firm has a market cap of $2.31 billion, a PE ratio of 29.19, a price-to-earnings-growth ratio of 2.30 and a beta of 1.04. Addus HomeCare has a 12-month low of $81.51 and a 12-month high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. During the same period last year, the firm posted $1.03 EPS. Addus HomeCare’s revenue for the quarter was up 7.1% on a year-over-year basis. As a group, equities research analysts forecast that Addus HomeCare will post 4.57 EPS for the current fiscal year.

Insider Activity

In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the sale, the director now owns 3,366 shares of the company’s stock, valued at $429,165. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 22,917 shares of company stock worth $3,050,082. Company insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

A number of large investors have recently bought and sold shares of the stock. Texas Permanent School Fund Corp lifted its position in shares of Addus HomeCare by 0.6% in the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock valued at $1,636,000 after acquiring an additional 82 shares in the last quarter. Arizona State Retirement System raised its stake in Addus HomeCare by 2.0% in the 2nd quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock valued at $527,000 after purchasing an additional 87 shares during the last quarter. UMB Bank n.a. raised its stake in Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after purchasing an additional 88 shares during the last quarter. Inspire Investing LLC lifted its holdings in Addus HomeCare by 3.3% in the 3rd quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock valued at $414,000 after purchasing an additional 100 shares in the last quarter. Finally, New York State Teachers Retirement System boosted its stake in shares of Addus HomeCare by 1.2% during the 3rd quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock worth $1,132,000 after purchasing an additional 100 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.